Sign In
Buy SOPH
$5.67
-0.0900 (-1.56%)
At Close: Jul 31, 2026
SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full Year of Fiscal 2022 on March 7, 2023
04:40pm, Thursday, 23'rd Feb 2023
BOSTON & LAUSANNE, Switzerland--(BUSINESS WIRE)---- $SOPH--SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced it will release its financial result
SOPHiA GENETICS to Present at the J.P. Morgan 2023 Healthcare Conference
04:02pm, Wednesday, 04'th Jan 2023
BOSTON & LAUSANNE, Switzerland--( BUSINESS WIRE )--SOPHiA GENETICS SA (NASDAQ: SOPH) today announced that Dr. Jurgi Camblong, Chief Executive Officer and Co-Founder, is scheduled to present at the J.P
SOPHiA GENETICS SA (SOPH) Q3 2022 Earnings Call Transcript
01:31pm, Saturday, 12'th Nov 2022
Start Time: 08:30 January 1, 0000 9:27 AM ET SOPHiA GENETICS SA (NASDAQ:SOPH ) Q3 2022 Earnings Conference Call November 08, 2022, 08:30 AM ET Company Participants Jurgi Camblong - Founder and CEO Ros
SOPHiA GENETICS SA (SOPH) Reports Q3 Loss, Tops Revenue Estimates
09:48am, Tuesday, 08'th Nov 2022
SOPHiA GENETICS SA (SOPH) delivered earnings and revenue surprises of -5.88% and 0.04%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
SOPHiA GENETICS to Participate in Upcoming November Investor Conferences
06:49am, Friday, 04'th Nov 2022
BOSTON and LAUSANNE, Switzerland, Nov. 04, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, announced today the company will be part
SOPHiA GENETICS to Announce Financial Results for the Third Quarter of Fiscal 2022 on November 8, 2022
07:01am, Thursday, 06'th Oct 2022
BOSTON and GENEVA, Switzerland, Oct. 06, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced it will release its financia
SOPHiA GENETICS to Participate in Fireside Chat at 20th Annual Morgan Stanley Global Healthcare Conference
07:00am, Friday, 02'nd Sep 2022
BOSTON and LAUSANNE, Switzerland, Sept. 02, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, announced today Chief Executive Officer
SOPHiA GENETICS SA (SOPH) CEO Dr. Jurgi Camblong on Q2 2022 Results - Earnings Call Transcript
05:48pm, Saturday, 13'th Aug 2022
SOPHiA GENETICS SA (NASDAQ:SOPH ) Q2 2022 Results Conference Call August 9, 2022 8:30 AM ET Company Participants Jennifer Pottage - Head, IR Dr. Jurgi Camblong - Co-Founder and CEO Ross Muken - CFO Co
SOPHiA GENETICS to Announce Financial Results for the Second Quarter of Fiscal 2022 on August 9, 2022
07:00am, Thursday, 14'th Jul 2022
BOSTON and LAUSANNE, Switzerland, July 14, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced it will release its financial results for the
SOPHiA GENETICS SA (SOPH) CEO Jurgi Camblong on Q1 2022 Results - Earnings Call Transcript
12:09pm, Saturday, 14'th May 2022
SOPHiA GENETICS SA (NASDAQ:SOPH ) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET Company Participants Jennifer Pottage - Head of IR Jurgi Camblong - Co-Founder, CEO and Director Ross Muken -
SOPHiA GENETICS to Announce Financial Results for the First Quarter of Fiscal 2022 on May 10, 2022
07:00am, Wednesday, 13'th Apr 2022
BOSTON and LAUSANNE, Switzerland, April 13, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced it will release its financial results for the
Sophia Genetics SA (SOPH) Q4 2021 Earnings Call Transcript
06:31pm, Tuesday, 15'th Mar 2022 The Motley Fool
SOPH earnings call for the period ending December 31, 2021.
SOPHiA GENETICS SA (SOPH) CEO Jurgi Camblong on Q4 2021 Results - Earnings Call Transcript
11:35am, Tuesday, 15'th Mar 2022
SOPHiA GENETICS SA (SOPH) CEO Jurgi Camblong on Q4 2021 Results - Earnings Call Transcript
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2021 Financial Results
11:02am, Tuesday, 15'th Mar 2022 GlobeNewswire Inc.
Revenues Grew 40% for the Fourth Quarter and 42% for Full Year 20212022 Guidance Reaffirmed
SOPHiA GENETICS to Participate in Fireside Chat at Barclays Global Healthcare Conference
01:00pm, Friday, 04'th Mar 2022 GlobeNewswire Inc.
BOSTON and LAUSANNE, Switzerland, March 04, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, announced today Chief Executive Officer and Co-Founder Dr. J
